RAFAEL HOLDINGS, INC. Other than Temporary Impairment Losses, Investments
RAFAEL HOLDINGS, INC. (RFL) reported Other than Temporary Impairment Losses, Investments of $334.00 thousand for the 12-month period ending 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2023-10-30
- RAFAEL HOLDINGS, INC. other than temporary impairment losses, investments for the quarter ending 2023-07-31 was -$17.00K.
- RAFAEL HOLDINGS, INC. other than temporary impairment losses, investments for the quarter ending 2023-04-30 was $128.00K.
- RAFAEL HOLDINGS, INC. other than temporary impairment losses, investments for the quarter ending 2023-01-31 was $67.00K.
- RAFAEL HOLDINGS, INC. other than temporary impairment losses, investments for the quarter ending 2022-10-31 was $156.00K.
- RAFAEL HOLDINGS, INC. other than temporary impairment losses, investments for fiscal 2023 was $334.00K.
- RAFAEL HOLDINGS, INC. other than temporary impairment losses, investments for fiscal 2021 was $724.00K, a 9.39% decline from fiscal 2020.
- RAFAEL HOLDINGS, INC. other than temporary impairment losses, investments for fiscal 2020 was $799.00K.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|---|---|---|
| 2023-07-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $111.00K derived: sum of 2 quarters · filed 2023-10-30 | $178.00K derived: sum of 3 quarters · filed 2023-10-30 | $334.00K 10-K · filed 2023-10-30 |
| 2023-04-30 | $128.00K 10-Q · filed 2023-06-13 | $195.00K derived: sum of 2 quarters · filed 2023-06-13 | $351.00K 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $67.00K 10-Q · filed 2023-03-14 | $223.00K 10-Q · filed 2023-03-14 | ||
| 2022-10-31 | $156.00K 10-Q · filed 2022-12-13 | |||
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2022-10-31 | $0.00 derived: sum of 3 quarters · filed 2022-10-31 | $724.00K 10-K · filed 2022-10-31 |
| 2021-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $0.00 derived: sum of 2 quarters · filed 2022-06-14 | $724.00K 10-Q · filed 2022-06-14 | $1.23M derived: sum of 4 quarters · filed 2022-06-14 |
| 2021-01-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $724.00K 10-Q · filed 2022-03-17 | $1.23M derived: sum of 3 quarters · filed 2022-03-17 | $1.52M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-10-31 | $724.00K 10-Q/A · filed 2022-02-28 | $1.23M derived: sum of 2 quarters · filed 2022-02-28 | $1.52M derived: sum of 3 quarters · filed 2022-02-28 | |
| 2020-07-31 | $504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $799.00K derived: sum of 2 quarters · filed 2021-10-18 | $799.00K 10-K · filed 2021-10-18 | |
| 2020-04-30 | $295.00K 10-Q · filed 2021-06-14 | $295.00K 10-Q · filed 2021-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |